郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes.

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2024作者：Jongmin Yoon; Don-Gil Lee; Haengjin Song; Dahae Hong; Ji Soo Park; Changhee Hong; Kyung Mi An; Jung Woo Lee; Joon-Tae Park; Hongchul Yoon; Jihoon Tak; Sang Geon Kim
阅读更多 →

代谢疾病Development of generic metabolic Raman calibration models using solution titration in aqueous phase and data augmentation for in-line cell culture analysis.

期刊：Biotechnology and bioengineering发表年份：2024作者：Zhijun Zhang; Zhe Lang; Gong Chen; Hang Zhou; Weichang Zhou
阅读更多 →

代谢疾病Raman-controlled pyruvate feeding to control metabolic activity and product quality in continuous biomanufacturing.

期刊：Biotechnology journal发表年份：2024作者：Patrick Romann; Sebastian Schneider; Daniela Tobler; Martin Jordan; Arnaud Perilleux; Jonathan Souquet; Christoph Herwig; Jean-Marc Bielser; Thomas K Villiger
阅读更多 →

代谢疾病Structure-activity relationships of thiadiazole agonists of the human secretin receptor.

期刊：SLAS discovery : advancing life sciences R & D发表年份：2024作者：Robert Ardecky; Daniela G Dengler; Kaleeckal G Harikumar; Mathew M Abelman; Jiwen Zou; Bryan A Kramer; Santhi Reddy Ganji; Steve Olson; Alina Ly; Nikhil Puvvula; Chen-Ting Ma; Raghuveer Ramachandra; Eduard A Sergienko; Laurence J Miller
阅读更多 →